Novo Nordisk Exec在特朗普的毒品定价新闻活动期间崩溃;公司否认他在场。 A Novo Nordisk exec collapsed during Trump’s drug pricing press event; company denies he was there.

在2025年11月6日的圆形办公室举行的新闻发布会中断,因为一名制药公司的高管在特朗普总统宣布与制药商达成协议时倒,降低价格并扩大对Zepbound和Wegovy等肥胖治疗的准入. A press conference in the Oval Office on November 6, 2025, was interrupted when a pharmaceutical executive collapsed during President Trump’s announcement of a deal with drugmakers to lower prices and expand access to obesity treatments like Zepbound and Wegovy. 此人被多个渠道点名为Novo Nordisk的Gordon Findlay,跪在膝盖上,并得到Mehmet Oz博士的协助。 The individual, identified by multiple outlets as Novo Nordisk’s Gordon Findlay, fell to his knees and was assisted by Dr. Mehmet Oz. 媒体被疏散,Trump后来说,执行官感到头晕,得到医疗照顾,一切正常。 The press were evacuated, and Trump later said the executive had felt lightheaded, received medical attention, and was fine. 倒塌的原因仍然未知。 The cause of the collapse remains unknown. Novo Nordisk后来说Findlay不在场,与初次报告相矛盾。 Novo Nordisk later stated Findlay was not present, contradicting initial reports. 事件发生在努力改善获得高成本减重药品的渠道。 The incident occurred amid efforts to improve access to high-cost weight-loss drugs.